Merck & Co. Inc.
MRKEquityAI Summary
Updated 8h ago
Merck & Co
Merck & Co. Inc. (MRK) is in a relatively unremarkable position right now. Momentum, flow, and extension indicators are all sitting near the middle of their historical ranges — none are signalling anything unusual. For reference: Flow Score 59/100, Trend & Momentum Score 82/100.
Market Positioning
What's Happening
Merck posted a Q1 beat and held guidance
On 2026-04-30, Merck reported Q1 2026 EPS of -$1.28, ahead of the consensus estimate of -$1.47, while revenue rose 4.9% year over year to $16.29 billion versus $15.85 billion expected. The more important detail is that management kept full-year 2026 guidance in a tight band — EPS of $5.04 to $5.16 and revenue of $65.8 billion to $67.0 billion — which tells you the core operating story is still intact even after a noisy quarter.
The Bigger Picture
Macro context will be updated shortly
Upcoming Catalysts
Updated 48d agoSome earnings calendars place Merck’s next report around this date, but this conflicts with Merck’s own investor-relations schedule. Treat it as a watch item only if the company updates timing, since the official date currently appears to be August 4.[2][5]
Merck’s investor relations calendar lists this as the next major reporting date. Investors will focus on whether management keeps full-year 2026 sales guidance of $65.8 billion to $67.0 billion and whether the earnings path is still consistent with consensus expectations.[5][1]
Technical Analysis
Market Positioning
Where does this asset sit across four dimensions? Extension (how stretched price is vs its own history), Momentum (RSI, MACD, rate of change), Flow (volume and money flow), and Volatility (how quiet or active). Each bar shows a 0–100 percentile compared to the last year of data. Key levels show the nearest demand and supply zones from our confluence analysis.
Looking at the full picture for Merck & Co. Inc. (MRK): extension is slightly above average (55th percentile), momentum is neutral (53rd percentile), flow is slightly above average (61st percentile), volatility is slightly below average (39th percentile). No dimension is showing an extreme reading right now. The indicators are not pointing to either a high-opportunity or high-risk setup — it is a wait-and-watch environment.
Where is money flowing?
Trend
Is momentum building or fading?
What is the relative strength?
How extended is this move?
Where are the key levels?
What risk am I taking?
Conclusion
Merck & Co. Inc. (MRK) sits in a relatively neutral position across all four dimensions — there is no extreme reading demanding attention right now. There is not a strong signal here in either direction. This is an asset to watch rather than act on right now. These readings update daily. Flipside shows what is happening now, grounded in the data — not what will happen next.
Your portfolio. Your context. Smarter decisions.
Connect your holdings and let the Flipside Agent analyze market changes through the lens of your portfolio.
Personalized insights based on your actual holdings
Major market movements delivered to your inbox
Track the assets that matter most to you
No credit card required